Skip to content
10-K

Annual Report

ENvue Medical, Inc. FEED

0001493152-26-016871

← back to feed
Filed
Apr 15, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Apr 15, 2026 3.7M sh
Shares Diluted FY 2025 · Dec 31, 2025 628.53K sh
Shares Diluted restated FY 2025 · Dec 31, 2024 26.99K sh
Capex FY 2025 · Dec 31, 2025 $60K
Capex FY 2025 · Dec 31, 2024 $3K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$9.37M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$2.52M
Cash And Equivalents FY 2025 · Dec 31, 2025 $4.22M
Cash And Equivalents FY 2025 · Dec 31, 2024 $752K
Stockholders Equity FY 2025 · Dec 31, 2025 $33.5M
Stockholders Equity FY 2025 · Dec 31, 2024 $627K
Stockholders Equity restated FY 2025 · Dec 31, 2023 $3.99M
Current Liabilities FY 2025 · Dec 31, 2025 $6.66M
Current Liabilities FY 2025 · Dec 31, 2024 $2.72M
Total Liabilities FY 2025 · Dec 31, 2025 $7.63M
Total Liabilities FY 2025 · Dec 31, 2024 $3M
Current Assets FY 2025 · Dec 31, 2025 $7.27M
Current Assets FY 2025 · Dec 31, 2024 $3.33M
Total Assets FY 2025 · Dec 31, 2025 $41.12M
Total Assets FY 2025 · Dec 31, 2024 $3.63M
Eps Diluted FY 2025 · Dec 31, 2025 −$26.69
Eps Diluted restated FY 2025 · Dec 31, 2024 −$137.30
Eps Basic FY 2025 · Dec 31, 2025 −$26.69
Eps Basic restated FY 2025 · Dec 31, 2024 −$137.30
Sga Expense FY 2025 · Dec 31, 2025 $7.63M
Sga Expense FY 2025 · Dec 31, 2024 $3.46M
Rd Expense FY 2025 · Dec 31, 2025 $1.76M
Rd Expense FY 2025 · Dec 31, 2024 $909K
Net Income FY 2025 · Dec 31, 2025 −$18.19M
Net Income FY 2025 · Dec 31, 2024 −$3.71M
Operating Income FY 2025 · Dec 31, 2025 −$22.89M
Operating Income FY 2025 · Dec 31, 2024 −$3.58M
Gross Profit FY 2025 · Dec 31, 2025 $153K
Gross Profit FY 2025 · Dec 31, 2024 $1.51M
Cost Of Revenue FY 2025 · Dec 31, 2025 $2.4M
Cost Of Revenue FY 2025 · Dec 31, 2024 $1.05M
Revenue FY 2025 · Dec 31, 2025 $2.55M
Revenue FY 2025 · Dec 31, 2024 $2.56M